OR WAIT null SECS
The solution, DLTA, is built on a project-management platform overlaid with knowledge of drug development and FDA requirements.
Aurotech, Inc., an established management and IT consulting firm is entering the pharmaceutical market with the launch of its Drug Lifecycle Tracking Application (DLTA). DLTA is built on a project-management platform overlaid with knowledge of drug development and FDA requirements. The result is custom-mapped workflow management for the entire drug development lifecycle. Users have the ability to track, manage and monitor projects from centralized dashboards and in-system collaboration for hand-offs between teams.
For CROs, DLTA can be implemented to improve clinical trial workflows across large teams or projects. For a pharmaceutical organization, the solution can function as an end-to-end work management platform, to replace disparate systems.
Read the full release.